Furthermore, NaHS exhibited neuroprotective properties in cardiac arrest models by reducing brain edema and BBB disruption through inhibition of matrix metalloproteinase-9 (MMP-9) expression and stabilization of occludin (Figure 2b, Table 1) [34]. The gene discussed is MMP9; the disease is cardiac arrest.